![](/img/cover-not-exists.png)
A novel dose-dense alternating regimen of Docetaxel-Cyclophosphamide with Epirubicin-Cisplatin (ddDCEP) as neoadjuvant chemotherapy (NACT) for high-risk triple-negative breast cancer
Georgy, J.T., Singh, A., Oommen, A., Joel, A., Manipadam, M.T., Abraham, D.T., Paul, M.J., Backianathan, S., Chacko, R.T.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.070
Date:
September, 2020
File:
PDF, 67 KB
2020